JP2009508952A5 - - Google Patents

Download PDF

Info

Publication number
JP2009508952A5
JP2009508952A5 JP2008532292A JP2008532292A JP2009508952A5 JP 2009508952 A5 JP2009508952 A5 JP 2009508952A5 JP 2008532292 A JP2008532292 A JP 2008532292A JP 2008532292 A JP2008532292 A JP 2008532292A JP 2009508952 A5 JP2009508952 A5 JP 2009508952A5
Authority
JP
Japan
Prior art keywords
alkyl
halo
group
optionally substituted
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2008532292A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009508952A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/036023 external-priority patent/WO2007035478A2/en
Publication of JP2009508952A publication Critical patent/JP2009508952A/ja
Publication of JP2009508952A5 publication Critical patent/JP2009508952A5/ja
Withdrawn legal-status Critical Current

Links

JP2008532292A 2005-09-20 2006-09-15 ナイアシン受容体アゴニスト、このような化合物を含有する組成物、および治療方法 Withdrawn JP2009508952A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71862205P 2005-09-20 2005-09-20
PCT/US2006/036023 WO2007035478A2 (en) 2005-09-20 2006-09-15 Niacin receptor agonists, compositions containing such compounds and methods of treatment

Publications (2)

Publication Number Publication Date
JP2009508952A JP2009508952A (ja) 2009-03-05
JP2009508952A5 true JP2009508952A5 (cg-RX-API-DMAC10.html) 2009-11-05

Family

ID=37889356

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008532292A Withdrawn JP2009508952A (ja) 2005-09-20 2006-09-15 ナイアシン受容体アゴニスト、このような化合物を含有する組成物、および治療方法

Country Status (6)

Country Link
US (1) US20110028462A1 (cg-RX-API-DMAC10.html)
EP (1) EP1940402A4 (cg-RX-API-DMAC10.html)
JP (1) JP2009508952A (cg-RX-API-DMAC10.html)
AU (1) AU2006292559A1 (cg-RX-API-DMAC10.html)
CA (1) CA2622960A1 (cg-RX-API-DMAC10.html)
WO (1) WO2007035478A2 (cg-RX-API-DMAC10.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5182088B2 (ja) 2006-04-19 2013-04-10 アステラス製薬株式会社 アゾールカルボキサミド誘導体
WO2009011872A1 (en) * 2007-07-17 2009-01-22 Merck & Co., Inc. Soluble epoxide hydrolase inhibitors, compositions containing such compounds and methods of treatment
SI2206707T1 (sl) * 2007-10-24 2014-11-28 Astellas Pharma Inc. Azolkarboksamidna spojina ali njena sol
EP2070916A1 (de) 2007-12-10 2009-06-17 Bayer Schering Pharma Aktiengesellschaft 2-Aryl-thiazol-4-carbonsäureamid-Derivate, deren Herstellung und Verwendung als Arzneimittel
EP2070925A1 (de) 2007-12-10 2009-06-17 Bayer Schering Pharma Aktiengesellschaft Neue 2-substituierte Tiazol-4-carbonsäureamid-Derivative deren Herstellung und Verwendung als Arzneimittel
EP2070924A1 (de) 2007-12-10 2009-06-17 Bayer Schering Pharma Aktiengesellschaft Neue 2-Hetarylthiazol-4-carbonsäureamid-Derivative, deren Herstellung und Verwendung als Arzneimittel
JP5990187B2 (ja) * 2010-12-16 2016-09-07 ニヴァリス・セラピューティクス・インコーポレーテッド S−ニトロソグルタチオン還元酵素阻害薬としての新規な置換二環芳香族化合物
KR102100470B1 (ko) 2015-08-21 2020-04-13 (주)오토파지사이언스 신규한 카테콜 유도체 및 이를 포함하는 약학적 조성물
US10254382B2 (en) * 2017-02-02 2019-04-09 Osram Sylvania Inc. System and method for determining vehicle position based upon light-based communication using signal-to-noise ratio or received signal strength indicator

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0319124D0 (en) * 2003-08-14 2003-09-17 Smithkline Beecham Corp Chemical compounds
WO2005034870A2 (en) * 2003-10-07 2005-04-21 Renovis, Inc. Amide compounds and ion channel ligands and uses thereof
GB0503056D0 (en) * 2005-02-14 2005-03-23 Smithkline Beecham Corp Chemical compounds
CA2641307A1 (en) * 2006-02-07 2007-08-16 Merck & Co., Inc. Niacin receptor agonists, compositions containing such compounds and methods of treatment
EP2010512A4 (en) * 2006-04-11 2010-02-24 Merck & Co Inc Niacin receptor agonists, compositions containing such compounds and method of treatment

Similar Documents

Publication Publication Date Title
JP2012524111A5 (cg-RX-API-DMAC10.html)
JP2011527334A5 (cg-RX-API-DMAC10.html)
JP2011513305A5 (cg-RX-API-DMAC10.html)
JP5837936B2 (ja) アルキルスルフィニル置換チアゾリド化合物
JP2010524932A5 (cg-RX-API-DMAC10.html)
JP2012505871A5 (cg-RX-API-DMAC10.html)
JP2006516622A5 (cg-RX-API-DMAC10.html)
JP2013505969A5 (cg-RX-API-DMAC10.html)
JP2006524222A5 (cg-RX-API-DMAC10.html)
NO20053211L (no) Forbindelser for behandling av metabolske forstyrrelser.
RU2009148673A (ru) Производные пиразинона и их применение для лечения легочных заболеваний
JP2007505931A5 (cg-RX-API-DMAC10.html)
JP2009533410A5 (cg-RX-API-DMAC10.html)
JP2010514832A5 (cg-RX-API-DMAC10.html)
EA200800476A1 (ru) Макроциклические ингибиторы вируса гепатита с
JP2013510825A5 (cg-RX-API-DMAC10.html)
JP2009532453A5 (cg-RX-API-DMAC10.html)
ME01421B (me) 5-supstituisani derivati kinazolinona kao protivtumorska sredstva
JP2012523457A5 (cg-RX-API-DMAC10.html)
NZ603594A (en) Certain amino-pyrimidines, compositions thereof, and methods for their use
JP2009519243A5 (cg-RX-API-DMAC10.html)
JP2009535307A5 (cg-RX-API-DMAC10.html)
DE602005005167D1 (de) 1-isopropyl-2-oxo-1,2-dihydropyridin-3-carbonsäureamidderivate mit agonistischer wirkung am 5-ht4-rezeptor
EA200601287A1 (ru) Производные (3-оксо-3,4-дигидрохиноксалин-2-иламино) бензамида и родственные соединения в качестве ингибиторов гликогенфосфорилазы для лечения диабета и ожирения
JP2010540593A5 (cg-RX-API-DMAC10.html)